首页 | 本学科首页   官方微博 | 高级检索  
     

低分子肝素对肾病综合征患者血浆组织纤溶酶原激活剂与D-二聚体水平的影响
引用本文:李丽慧,王玉华,焦殿明. 低分子肝素对肾病综合征患者血浆组织纤溶酶原激活剂与D-二聚体水平的影响[J]. 沈阳医学院学报, 2000, 0(1)
作者姓名:李丽慧  王玉华  焦殿明
作者单位:沈阳医学院附属二院肾内科!沈阳110002(李丽慧,王玉华),沈阳医学院附属二院中心实验室!沈阳110002(焦殿明)
摘    要:
目的 探讨低分子肝素 (L MWH)的溶栓作用。方法 用底物显色法和ELISA法测定肾病综合征 (NS)患者应用 LMWH前后血浆组织型纤溶酶原激活剂 (t- PA)与 D-二聚体 (D- D)的水平。结果 皮下注射 LMWH组血浆 t- PA与 D- D水平明显增高 ,而静脉滴注 LMWH组血浆 t- PA与 D- D水平无明显变化。结论 皮下注射 L MWH有明显溶栓作用。

关 键 词:低分子肝素  肾病综合征  组织型纤溶酶原激活剂  D-二聚体  纤溶酶原

Effects of Low Molecular Weight Heparin on Plasma Tissue-Type Plasminogen Activitor and D-dimer in Patients with Nephrotic Syndrome
Li Lihui,Wang Yuhua,Jiao Dianming. Effects of Low Molecular Weight Heparin on Plasma Tissue-Type Plasminogen Activitor and D-dimer in Patients with Nephrotic Syndrome[J]. Journal of Shenyang Medical College, 2000, 0(1)
Authors:Li Lihui  Wang Yuhua  Jiao Dianming
Abstract:
Objective To explore thrombolysis action of low molecular weight heparin(LMWH).Methods The patients with nephrotic syndrome(NS) were measured for their plasma levels of tissue type plasminogen activitor(t PA) by chromogenic substrate method and ELISA before and after using LMWH.Results Plasma t PA and D D levels were clearly increased in LMWH sabcutaneous injection group.But the changes of them in LMWH intravenons drip group were not obvious.Conclusion LMWH subcutaneous injection had thrombolysis action
Keywords:low molecular weight heparin(LMWH)  nephrotic syndnome(NS)  tissue type plasminogen activitor(t PA)  D dimer(D D)  plasminogen(PLG)
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号